Mittal C. Patel, MD
Family Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 4
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Patel’s office at (408) 493-5144 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A76093 · Current
Licensed to practise in California · since 2001 · expires 2027-06-30 · South Gujarat University, Government Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$25,230 in 2019
Medicaid paid $25,230 for 236 billed services this clinician did in 2019, up to 57 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 176 | $25,230 |
| Short return visit (20+ min) | 43 | $0 |
| Return visit (30+ min) | 17 | $0 |
| 2019 | 236 | 3 | 57 | $25,230 |
| 2018 | 24 | 1 | 22 | $3,512 |
See the largest Medicaid services in earlier years
2018
| Clinic visit/encounter, all-inclusive | 24 | $3,512 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 110 Part D prescriptions in 2019.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2019 | 110 | 38 | 0% (0) | None | $3,109 |
| 2018 | 82 | 18 | 0% (0) | None | $3,193 |
| 2017 | 118 | 19 | None | None | $5,748 |
| 2016 | 356 | 53 | None | 7% | $13,072 |
| 2015 | 466 | 62 | 3% (12) | 14% | $22,033 |
| 2014 | 559 | 52 | 2% (11) | 19% | $25,403 |
| 2013 | 555 | 48 | 3% (17) | None | $23,435 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Atorvastatin | 11 | $76 | $7 |
2017: 1 drug
| Amlodipine Besylate-Benazepril | 11 | $233 | $21 |
2016: 9 drugs
| Pravastatin | 13 | $472 | $36 |
| Simvastatin | 38 | $328 | $9 |
| Atorvastatin | 27 | $312 | $12 |
| Levothyroxine | 14 | $305 | $22 |
| Amlodipine Besylate | 39 | $203 | $5 |
| Metformin | 18 | $193 | $11 |
| Losartan | 14 | $167 | $12 |
| Lisinopril | 24 | $119 | $5 |
| Metoprolol | 14 | $58 | $4 |
2015: 11 drugs
| Pravastatin | 21 | $674 | $32 |
| Levothyroxine | 34 | $590 | $17 |
| Simvastatin | 38 | $310 | $8 |
| Lovastatin | 16 | $235 | $15 |
| Lisinopril | 50 | $216 | $4 |
| Metformin | 16 | $201 | $13 |
| Losartan | 23 | $187 | $8 |
| Atorvastatin | 13 | $140 | $11 |
| Fluticasone Propionate | 12 | $106 | $9 |
| Amlodipine Besylate | 30 | $106 | $4 |
| Hydrochlorothiazide | 11 | $24 | $2 |
2014: 11 drugs
| Pravastatin | 24 | $634 | $26 |
| Levothyroxine | 29 | $558 | $19 |
| Lisinopril | 76 | $480 | $6 |
| Losartan | 32 | $394 | $12 |
| Metformin | 23 | $362 | $16 |
| Sertraline | 15 | $330 | $22 |
| Atorvastatin | 25 | $273 | $11 |
| Simvastatin | 23 | $210 | $9 |
| Amlodipine Besylate | 23 | $112 | $5 |
| Hydrochlorothiazide | 11 | $92 | $8 |
| Glipizide | 11 | $87 | $8 |
2013: 20 drugs
| Janumet | 12 | $3,111 | $259 |
| Diovan | 11 | $2,578 | $234 |
| Lantus | 11 | $1,657 | $151 |
| Premarin | 11 | $930 | $85 |
| Oxybutynin Chloride Er | 13 | $925 | $71 |
| Atorvastatin | 35 | $850 | $24 |
| Losartan | 39 | $506 | $13 |
| Lisinopril | 48 | $494 | $10 |
| Pioglitazone | 12 | $375 | $31 |
| Sertraline | 23 | $341 | $15 |
| Levothyroxine | 34 | $338 | $10 |
| Metformin | 21 | $276 | $13 |
| Amlodipine Besylate | 18 | $233 | $13 |
| Simvastatin | 18 | $229 | $13 |
| Alendronate | 14 | $222 | $16 |
| Omeprazole | 16 | $165 | $10 |
| Atenolol | 17 | $151 | $9 |
| Ranitidine | 12 | $54 | $5 |
| Hydrochlorothiazide | 12 | $43 | $4 |
| Metoprolol | 15 | $16 | $1 |
Money from drug and device companies
$42 in 2025
| 2025 | 1 | 1 | None | $42 |
| 2024 | 1 | 6 | None | $178 |
| 2023 | 2 | 2 | None | $95 |
| 2022 | 1 | 4 | None | $145 |
| 2021 | 1 | 4 | None | $176 |
| 2020 | 2 | 3 | None | $63 |
| 2019 | 1 | 1 | $450 | $450 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Revance Therapeutics | Daxxify | $42 | 1 payment
|
See the published payment
| Revance Therapeutics | Meals · 2025-05-07 | Daxxify | $42 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $178
| Abbvie | Botox | $178 | 6 payments
|
2023: $95
| Merz North America | None | $70 | 1 payment
|
| Abbvie | None | $25 | 1 payment
|
2022: $145
| Allergan | Botox | $145 | 4 payments
|
2021: $176
| Allergan | None | $176 | 4 payments
|
2020: $63
| Amarin Pharma | Vascepa | $39 | 2 payments
|
| Allergan | None | $25 | 1 payment
|
2019: $450
| Galderma Laboratories L.P. | None | $450 | 1 payment
|
Professional record
- NPI
- 1376621870
- Licence
- CA A76093California A76093: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A760930
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 2505 Samaritan Dr, Suite 505, San Jose, CA, 95124
- NPI first listed
- 2006-11-01
- NPI last updated
- 2025-05-05
- NPI record certified
- 2025-05-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2242 Camden Ave Ste 102, San Jose, CA, 95124